C2N Diagnostics Competitors and Similar CompaniesClear all
C2N Diagnostics's competitors and similar companies include ZZ Biotech and Alseres Pharmaceuticals.
 C2N Diagnostics C2N Diagnostics is a company that develops and commercializes diagnostics for Alzheimer’s disease and related forms of neurodegeneration. |  ZZ Biotech ZZ Biotech is a company developing biological treatments for ischemic stroke and other neurological diseases. |  Alseres Pharmaceuticals Alseres Pharmaceuticals, Inc. (ALSE) is focused on the development of diagnostic and therapeutic products for disorders in the central nervous system (CNS). | |
Founding Date | Founding Date 2007 | Founding Date 2006 | Founding Date 1972 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations St. Louis, US HQ | Locations Houston, US HQ Sydney, AU | Locations Newton, US HQ |
Employees | Employees 96 | Employees 6810% increase | Employees 4 |
Funding | |||
Latest funding round | Latest funding round $ 20m (about 6 years ago) | Latest funding round $ 6.9m (over 11 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 20m | Total funding raised $ 7.9m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
ZZ Biotech
HQ
Houston, US
Employees
68↑ 10% increase
ZZ Biotech is a company developing biological treatments for ischemic stroke and other neurological diseases.
View companyAlseres Pharmaceuticals
HQ
Newton, US
Employees
4
Alseres Pharmaceuticals, Inc. (ALSE) is focused on the development of diagnostic and therapeutic products for disorders in the central nervous system (CNS).
View company